Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, NY, 10010, USA.
Biology Program, Division of Science and Mathematics, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Cell Calcium. 2020 May;87:102187. doi: 10.1016/j.ceca.2020.102187. Epub 2020 Feb 28.
Calcium (Ca) release-activated Ca (CRAC) channels mediated by STIM1/2 and ORAI (ORAI1-3) proteins form the dominant store-operated Ca entry (SOCE) pathway in a wide variety of cells. Among these, the enamel-forming cells known as ameloblasts rely on CRAC channel function to enable Ca influx, which is important for enamel mineralization. This key role of the CRAC channel is supported by human mutations and animal models lacking STIM1 and ORAI1, which results in enamel defects and hypomineralization. A number of recent reports have highlighted the role of the chanzyme TRPM7 (transient receptor potential melastanin 7), a transmembrane protein containing an ion channel permeable to divalent cations (Mg, Ca), as a modulator of SOCE. This raises the question as to whether TRPM7 should be considered an alternative route for Ca influx, or if TRPM7 modifies CRAC channel activity in enamel cells. To address these questions, we monitored Ca influx mediated by SOCE using the pharmacological TRPM7 activator naltriben and the inhibitor NS8593 in rat primary enamel cells and in the murine ameloblast cell line LS8 cells stimulated with thapsigargin. We also measured Ca dynamics in ORAI1/2-deficient (shOrai1/2) LS8 cells and in cells with siRNA knock-down of Trpm7. We found that primary enamel cells stimulated with the TRPM7 activator potentiated Ca influx via SOCE compared to control cells. However, blockade of TRPM7 with NS8593 did not decrease the SOCE peak. Furthermore, activation of TRPM7 in shOrai1/2 LS8 cells lacking SOCE failed to elicit Ca influx, and Trpm7 knock-down had no effect on SOCE. Taken together, our data suggest that TRPM7 is a positive modulator of SOCE potentiating Ca influx in enamel cells, but its function is fully dependent on the prior activation of the ORAI channels.
钙(Ca)释放激活的钙(CRAC)通道由 STIM1/2 和 ORAI(ORAI1-3)蛋白介导,在多种细胞中形成主要的储存操纵钙进入(SOCE)途径。在这些细胞中,形成牙釉质的细胞即成釉细胞依赖于 CRAC 通道功能来实现 Ca 内流,这对于牙釉质矿化很重要。CRAC 通道的这个关键作用得到了人类突变和缺乏 STIM1 和 ORAI1 的动物模型的支持,这些突变和模型导致了牙釉质缺陷和矿化不足。最近的一些报告强调了 chanzyme TRPM7(瞬时受体电位黑素体 7)的作用,TRPM7 是一种跨膜蛋白,包含对二价阳离子(Mg、Ca)通透的离子通道,作为 SOCE 的调节剂。这就提出了一个问题,即 TRPM7 是否应该被视为 Ca 内流的替代途径,或者 TRPM7 是否修饰了成釉细胞中的 CRAC 通道活性。为了解决这些问题,我们使用药理学 TRPM7 激活剂 naltriben 和抑制剂 NS8593 监测 SOCE 介导的 Ca 内流,在原代大鼠成釉细胞和经 thapsigargin 刺激的小鼠成釉细胞瘤系 LS8 细胞中进行。我们还测量了 ORAI1/2 缺陷(shOrai1/2)LS8 细胞和 Trpm7 siRNA 敲低细胞中的 Ca 动力学。我们发现,与对照细胞相比,用 TRPM7 激活剂刺激的原代成釉细胞增强了 SOCE 介导的 Ca 内流。然而,用 NS8593 阻断 TRPM7 并没有降低 SOCE 峰值。此外,在缺乏 SOCE 的 shOrai1/2 LS8 细胞中激活 TRPM7 未能引起 Ca 内流,并且 Trpm7 敲低对 SOCE 没有影响。总之,我们的数据表明,TRPM7 是 SOCE 的正调节剂,增强了成釉细胞中的 Ca 内流,但它的功能完全依赖于 ORAI 通道的先前激活。